Rabaptin-5β Activators
Rabaptin-5β activators encompass a diverse range of compounds that influence endosomal trafficking and membrane fusion, pathways where Rabaptin-5β plays a pivotal role. GTP, as the primary energy source for Rab proteins, directly enhances Rabaptin-5β activity by promoting its interaction with GTP-bound Rab, essential for endocytic membrane fusion. Chloroquine and Monensin, through their impact on endosomal pH, indirectly augment Rabaptin-5β function in membrane trafficking. Brefeldin A and Nocodazole, by disrupting the Golgi apparatus and microtubules respectively, lead to changes in intracellular transport dynamics, indirectly enhancing Rabaptin-5β's role in endocytic pathways. Wortmannin and YM201636, by altering vesicle formation and phosphoinositide metabolism, respectively, modulate endosomal trafficking, thereby enhancing Rabaptin-5β activity in these processes.
Furthermore, Dynasore, by inhibiting dynamin, affects vesicle scission, leading to alterations in endosomal trafficking where Rabaptin-5β is critical, thereby enhancing its activity. U18666A, through its impact on cholesterol transport, indirectly augments Rabaptin-5β's role in endosome and lysosome function. Forskolin, by raising cAMP levels, influences various cellular processes, including endosomal trafficking, indirectly enhancing Rabaptin-5β activity. Vinblastine and EIPA (5-(N-Ethyl-N-isopropyl)amiloride), by disrupting microtubules and affecting endosomal pH respectively, lead to changes in endosomal trafficking dynamics, further augmenting the role of Rabaptin-5β in these processes. Collectively, these activators, through their targeted effects on cellular transport and endosomal dynamics, significantly enhance the functional activity of Rabaptin-5β, a key player in endocytic membrane fusion and trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, known for its use in treating malaria, accumulates in endosomes and affects their pH. This alteration can enhance Rabaptin-5β activity by modulating endosomal functions, where Rabaptin-5β is actively involved in membrane trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, a polyether antibiotic, alters endosomal and lysosomal pH. This perturbation can indirectly enhance Rabaptin-5β activity by affecting the endosomal trafficking pathways in which Rabaptin-5β is involved. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and affects vesicular trafficking. By modulating endosomal trafficking, Brefeldin A can indirectly enhance Rabaptin-5β activity in endocytic membrane fusion. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, a microtubule-depolymerizing agent, disrupts intracellular transport. This disruption can indirectly enhance Rabaptin-5β activity by affecting the dynamics of endosomal trafficking, where Rabaptin-5β plays a role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3 kinase inhibitor, affects endosomal trafficking by inhibiting vesicle formation. This can enhance Rabaptin-5β activity by modifying the endosomal pathway dynamics in which Rabaptin-5β is involved. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
YM201636, a PIKfyve inhibitor, affects phosphoinositide metabolism, thereby influencing endosomal trafficking. This modulation can indirectly enhance Rabaptin-5β activity in endocytic membrane fusion processes. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore, a GTPase inhibitor, specifically inhibits dynamin, affecting vesicle scission. This can indirectly enhance Rabaptin-5β activity by altering the endosomal trafficking, where Rabaptin-5β is critical. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A, an inhibitor of cholesterol transport, affects endosome and lysosome function. This perturbation can enhance Rabaptin-5β activity by modulating the endosomal trafficking pathways crucial for its function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, raises cAMP levels, affecting various cellular processes including endosomal trafficking. This can enhance Rabaptin-5β activity by indirectly influencing the endocytic pathways it regulates. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine, a microtubule-disrupting agent, affects intracellular transport. This disruption can enhance Rabaptin-5β activity by altering the dynamics of endosomal trafficking, a key area of Rabaptin-5β function. | ||||||